Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial

Gareth J Hollands, Sophia C L Whitwell, Richard A Parker, Natalie J Prescott, Alastair Forbes, Jeremy Sanderson, Christopher G Mathew, Cathryn M Lewis, Sally Watts, Stephen Sutton, David Armstrong, Ann Louise Kinmonth, A Toby Prevost, Theresa M Marteau

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


To test the hypothesis that communicating risk of developing Crohn's disease based on genotype and that stopping smoking can reduce this risk, motivates behaviour change among smokers at familial risk.
Original languageEnglish
Pages (from-to)e4708
Publication statusPublished - 2012


  • Adult
  • Attitude to Health
  • Crohn Disease
  • DNA Mutational Analysis
  • Family
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Great Britain
  • Humans
  • Male
  • Middle Aged
  • Motivation
  • Nod2 Signaling Adaptor Protein
  • Outcome Assessment (Health Care)
  • Risk Assessment
  • Smoking
  • Smoking Cessation

Cite this